CXCR4 and breast carcinoma: Additionally, studies by Ramos et al. and Dayer et al. corroborated the proposed perspective that the DNA methylation status of CXCR4 and CXCL12 genes could be used as biomarkers for breast cancer prognosis (Ramos et al., 2011; Dayer et al., 2018).